Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07199309 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 6, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date changed from estimate of Sep 2025 to Sep 26, 2025v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.
Trial Details
NCT Number NCT07199309
Lead Sponsor Marea Therapeutics
Conditions
(from sponsor)		 Hypertriglyceridemia
Related terms Hypertriglyceridemia
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov